I would remove the phrase "obvious curative effects" from your description as it implies that you already know the results of your protocol.
REVIEWER
Janneke wilschut Amsterdam University Medical Center, the Netherlands REVIEW RETURNED 04-Jun-2019
GENERAL COMMENTS
1. PLease add a reference to the Montreal definition in the introduction 2. I miss time lines for the study.
3. Which data will be added in the data template on study charateristerics and patients?
4. Could a bit more detail be added on the methods to be used in Revman?
5. Please explicitly mention the potential reasons for heterogeneity you want to explore (instead of saying etc.)
REVIEWER

Yiwei Zhang
Merck & Co., USA REVIEW RETURNED 09-Jun-2019
GENERAL COMMENTS
The paper designs a meta-data analysis protocol for estimating the effect of acupuncture for refractory gastro-oesophageal reflux disease (GORD). The paper states that some existing approaches for GORD, such as proton pump inhibitor or surgery, are not very effective and might cause serious adverse events, but complementary and alternative medicine, especially acupuncture, may bring new hope to GORD. A meta-analysis conducted by Zhu et al. (2017) showed that acupuncture is effective, however the analysis had small sample size and included poor methodological quality of trials. The present paper hence proposes a much more comprehensive meta-analysis for estimating the effect of acupuncture. The paper has clear and detailed descriptions of study selection criteria, data extraction and management and data analysis methodology. However, it would be better for the paper to clarify or discuss the following points. Introduction (page 6-7) The ideal candidate for anti-reflux surgery is not one who fails to respond to adequate medical therapy but one who has satisfactory response but at a higher dosing. Of course, pH studies and manometry should confirm the diagnosis of GORD and adequate acid suppression, and clarify the pressure morphology
Reply: As you said, unfavorable outcomes were reported after anti-reflux surgery in poor responders to PPIs, but what we want to mean is that anti-reflux surgery is one of options for rGORD, not the best one. Also, we have revised the description in the mentioned part.
Methods (page 9) Primary outcomes Severity and intensity have been listed as two endpoints; the difference n meaning should be clarified
Reply: By mentioning severity and intensity, we just want to mean the strength of main symptoms, and we have revised it.
Methods (page 10-11) Selection of studies The last paragraph on page 10 starts in the past tense (as if the study has already been initiated) and ends in the future tense (study to be started); this language issue should be rectified
Reply: Revision has been made in that part.
Reviewer: 2 Reply: Thanks for your comments, and much more information has been added to that part.
Reply: Thank you for your advice, and we have revised it.
Reviewer: 3 Reviewer Name: Janneke wilschut Institution and Country: Amsterdam University Medical Center, the Netherlands Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below
PLease add a reference to the Montreal definition in the introduction
Reply: The reference has been added.
2. I miss time lines for the study.
Reply: The study has not been started.
Reply: Numbers, publishing date and origins of included trials will be added in the data template, as well as numbers and average age of include patients both in trial and control groups.
Reply: More details have been added in the part of Data synthesis. Reply: Guided by the Cochrane handbook, this study will select trials strictly based on inclusion and exclusion criteria, which will lead to representativeness of included studies. Thus, there is no need to weigh included trials in different time frame differently.
2. As mentioned in the paper, different studies have different measurements for the efficacy of acupuncture. Can the paper discuss how to treat those measurements differently or what the correlations of those measurements are?
Reply: Since primary and secondary outcomes have been defined, only studies with those outcomes will be included in our analysis. Measurements for the same outcome in different included trials should not be different. But it do exist that only some of included studies are with primary outcomes. Under this circumstance, the analysis about this outcome will include these studies only, and other included studies will not be analyzed for this outcome.
3. When chi-square test and I-squared statistic are used together to assess the heterogeneity, they sometimes show different conclusions since those statistic focus on different aspects of testing heterogeneity. Can the paper discuss how to deal with this case?
Reply: Since heterogeneity is always unavoidable, when results of chi-square test and I-squared statistic are different, we will use a random effects model as much as possible (50% 
